Comparison of aripiprazole augmentation versus bupropion combination for patient with major depressive disorder

被引：1
|
作者：
Lee, K. [1 ]
Lee, J. B. [2 ]
Park, Y. W. [3 ]
Lee, J. H. [4 ]
Lee, S. J. [5 ]
Koo, B. H. [5 ]
Sung, H. M. [6 ]
Cheon, E. J. [5 ]
机构：
[1] Dongguk Univ Hosp, Psychiat, Gyeongjy, South Korea
[2] Yeungnam Univ Hosp, Psychiat, Daegu, South Korea
[3] Fatima Hosp, Psychiat, Daegu, South Korea
[4] Catholic Univ Daegu Hosp, Psychiat, Daegu, South Korea
[5] Kyungpook Univ Hosp, Psychiat, Daegu, South Korea
[6] Cha Univ Hosp, Psychiat, Gumi, South Korea
来源：
EUROPEAN NEUROPSYCHOPHARMACOLOGY | 2014年 / 24卷
关键词：
D O I：
10.1016/S0924-977X(14)70724-2
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P.2.f.003
引用
收藏
页码：S452 / S453
页数：2
相关论文
共 50 条
  • [1] Comparison of lithium, aripiprazole and olanzapine as augmentation to paroxetine for inpatients with major depressive disorder
    Yoshimura, Reiji
    Hori, Hikaru
    Umene-Nakano, Wakako
    Ikenouchi-Sugita, Atsuko
    Katsuki, Asuka
    Atake, Kiyokazu
    Nakamura, Jun
    THERAPEUTIC ADVANCES IN PSYCHOPHARMACOLOGY, 2014, 4 (03) : 123 - 129
  • [2] Aripiprazole monotherapy in a patient with major depressive disorder
    Yokoyama, Yuichi
    Kitamura, Hideaki
    Someya, Toshiyuki
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2010, 34 (06): : 1124 - 1125
  • [3] Comparison of the Efficacy and Safety of Aripiprazole Versus Bupropion Augmentation in Patients With Major Depressive Disorder Unresponsive to Selective Serotonin Reuptake Inhibitors: A Randomized, Prospective, Open-Label Study
    Cheon, Eun-Jin
    Lee, Kwang-Hun
    Park, Young-Woo
    Lee, Jong-hun
    Koo, Bon-Hoon
    Lee, Seung-Jae
    Sung, Hyung-Mo
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2017, 37 (02) : 193 - 199
  • [4] Bupropion in the treatment of major depressive disorder: a comparison with paroxetine
    Calandra, C.
    Terranova, F.
    Loiacono, P.
    Caudullo, V.
    Russo, R. G.
    Luca, M.
    Cafiso, M.
    JOURNAL OF PSYCHOPATHOLOGY, 2010, 16 (01): : 128 - 133
  • [5] DOUBLE-BLIND COMPARISON OF DOXEPIN VERSUS BUPROPION IN OUTPATIENTS WITH A MAJOR DEPRESSIVE DISORDER
    FEIGHNER, J
    HENDRICKSON, G
    MILLER, L
    STERN, W
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 1986, 6 (01) : 27 - 32
  • [6] Aripiprazole - In major depressive disorder
    Weber, Juliane
    Lyseng-Williamson, Katherine A.
    Scott, Lesley J.
    CNS DRUGS, 2008, 22 (10) : 807 - 813
  • [7] Switching, combination, and augmentation strategies for major depressive disorder
    Papakostas, George I.
    ANNALS OF CLINICAL PSYCHIATRY, 2010, 22 (04) : S9 - S14
  • [8] Bupropion SR augmentation strategy in mirtazapine major depressive disorder incomplete responders
    Vasile, D.
    Vasiliu, O.
    Vasile, M.
    Cretu, O.
    Ojog, D.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2008, 11 : 197 - 197
  • [9] Profiling the combination of bupropion and dextromethorphan as a treatment option for major depressive disorder
    Blanco, Joseph
    Quimbaya, Pamela
    Mena, Manuel
    Dodd, Seetal
    Bustos, Rosa-Helena
    EXPERT REVIEW OF NEUROTHERAPEUTICS, 2024, 24 (09) : 837 - 848
  • [10] The combination of duloxetine and bupropion for treatment-resistant major depressive disorder
    Papakostas, GI
    Worthington, JJ
    Iosifescu, DV
    Kinrys, G
    Burns, AM
    Fisher, LB
    Homberger, CH
    Mischoulon, D
    Fava, M
    DEPRESSION AND ANXIETY, 2006, 23 (03) : 178 - 181
12345